Equilis® Prequenza, Suspension for injection for horses
Equilis Prequenza provides active immunisation against equine influenza using the whole influenza virus and Iscom-Matrix adjuvant technology.
Presentation
Clear opalescent suspension
Active ingredients
Per dose of 1 ml:
Equine influenza virus strains:
A/equine-2/ South Africa/4/03 - 50 AU1
A/equine-2/ Newmarket/2/93 - 50 AU1
1 Antigenic Units
Target species
Horses
Indications for use
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection.
|
Onset of immunity: |
2 weeks after completion of the primary vaccination course. |
|---|---|
|
Duration of immunity: |
5 months after completion of the primary vaccination course. 1 year after the first revaccination. |
Withdrawal periods
Horses - zero days
Packaging
Cardboard box with 10 glass vials of 1 ml (1 dose)
Cardboard box with 5 pre-filled syringes of 1 ml (1 dose) with needles
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: September 2024